BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kordik CP, Reitz AB. Pharmacological Treatment of Obesity:  Therapeutic Strategies. J Med Chem 1999;42:181-201. [DOI: 10.1021/jm980521l] [Cited by in Crossref: 119] [Cited by in F6Publishing: 99] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Dehli JR, Gotor V. Stereoselective alkylation–reduction of β-keto nitriles by the fungus Curvularia lunata. Tetrahedron: Asymmetry 2001;12:1485-92. [DOI: 10.1016/s0957-4166(01)00269-5] [Cited by in Crossref: 27] [Article Influence: 1.3] [Reference Citation Analysis]
2 Belen’kii L, Kruchkovskaya N, Gramenitskaya V. The Literature of Heterocyclic Chemistry, Part VII: 1997–1999. Elsevier; 2001. pp. 199-318. [DOI: 10.1016/s0065-2725(01)79024-1] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
3 Cottineau B, Toto P, Marot C, Pipaud A, Chenault J. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids. Bioorganic & Medicinal Chemistry Letters 2002;12:2105-8. [DOI: 10.1016/s0960-894x(02)00380-3] [Cited by in Crossref: 147] [Cited by in F6Publishing: 14] [Article Influence: 7.4] [Reference Citation Analysis]
4 Giancarlo S, Rosa LM, Nadjafi F, Francesco M. Hypoglycaemic activity of two spices extracts: Rhus coriaria L. and Bunium persicum Boiss. Nat Prod Res. 2006;20:882-886. [PMID: 16753927 DOI: 10.1080/14786410500520186] [Cited by in Crossref: 65] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
5 Uvarani C, Sankaran M, Jaivel N, Chandraprakash K, Ata A, Mohan PS. Bioactive dimeric carbazole alkaloids from Murraya koenigii. J Nat Prod 2013;76:993-1000. [PMID: 23691929 DOI: 10.1021/np300464t] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
6 Webb P. Selective activators of thyroid hormone receptors. Expert Opin Investig Drugs 2004;13:489-500. [PMID: 15155124 DOI: 10.1517/13543784.13.5.489] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
7 Gavai A, Sher P, Mikkilineni A, Poss K, Mccann P, Girotra R, Fisher L, Wu G, Bednarz M, Mathur A, Wang T, Sun C, Slusarchyk D, Skwish S, Allen G, Hillyer D, Frohlich B, Abboa-offei B, Cap M, Waldron T, George R, Tesfamariam B, Harper T, Ciosek C, Young D, Dickinson K, Seymour A, Arbeeny C, Washburn W. BMS-196085: A potent and selective full agonist of the human β3 adrenergic receptor. Bioorganic & Medicinal Chemistry Letters 2001;11:3041-4. [DOI: 10.1016/s0960-894x(01)00629-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Shimokawa K, Yamada K, Kita M, Uemura D. Convergent synthesis and in vivo inhibitory effect on fat accumulation of (-)-ternatin, a highly N-methylated cyclic peptide. Bioorg Med Chem Lett 2007;17:4447-9. [PMID: 17590333 DOI: 10.1016/j.bmcl.2007.06.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
9 Mattes RD, Bormann L. Effects of (−)-hydroxycitric acid on appetitive variables. Physiology & Behavior 2000;71:87-94. [DOI: 10.1016/s0031-9384(00)00321-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
10 Liu D, Xie W, Liu L, Xu J, Yao H, Tanabe G, Muraoka O, Wu X. Practical Synthesis of Neoponkoranol and its Related Sulfonium Salt, an Optimised Protocol using Isopropylidene as an Effective Protecting Group. Journal of Chemical Research 2019;37:715-9. [DOI: 10.3184/174751913x13823645011477] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nasi R, Sim L, Rose DR, Pinto BM. Synthesis and glycosidase inhibitory activities of chain-modified analogues of the glycosidase inhibitors salacinol and blintol. Carbohydrate Research 2007;342:1888-94. [DOI: 10.1016/j.carres.2007.02.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kushner RF, Manzano H. Obesity pharmacology: past, present, and future: . Current Opinion in Gastroenterology 2002;18:213-20. [DOI: 10.1097/00001574-200203000-00011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
13 Jin F, Lu C, Sun X, Li W, Liu G, Tang Y. Insights into the binding modes of human β3-adrenergic receptor agonists with ligand-based and receptor-based methods. Mol Divers 2011;15:817-31. [DOI: 10.1007/s11030-011-9311-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
14 De Amici M, De Micheli C, Kassi L, Carrea G, Ottolina G, Colombo G. β 3 -Adrenergic receptor ligands: insight into structure–activity relationships using Monte-Carlo conformational analysis in water. Tetrahedron 2001;57:1849-55. [DOI: 10.1016/s0040-4020(00)01165-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
15 Lindblom J, Kask A, Hägg E, Härmark L, Bergström L, Wikberg J. Chronic infusion of a melanocortin receptor agonist modulates dopamine receptor binding in the rat brain. Pharmacol Res 2002;45:119-24. [PMID: 11846623 DOI: 10.1006/phrs.2001.0913] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
16 Wei G, Yu B. Isoflavone Glycosides: Synthesis and Evaluation as α-Glucosidase Inhibitors. Eur J Org Chem 2008;2008:3156-63. [DOI: 10.1002/ejoc.200800239] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
17 Somsák L, Nagy V, Docsa T, Tóth B, Gergely P. Gram-scale synthesis of a glucopyranosylidene-spiro-thiohydantoin and its effect on hepatic glycogen metabolism studied in vitro and in vivo. Tetrahedron: Asymmetry 2000;11:405-8. [DOI: 10.1016/s0957-4166(99)00486-3] [Cited by in Crossref: 30] [Article Influence: 1.4] [Reference Citation Analysis]
18 Tasler S, Baumgartner R, Ammendola A, Schachtner J, Wieber T, Blisse M, Rath S, Zaja M, Klahn P, Quotschalla U, Ney P. Thienopyrimidines as β3-adrenoceptor agonists: Hit-to-lead optimization. Bioorganic & Medicinal Chemistry Letters 2010;20:6108-15. [DOI: 10.1016/j.bmcl.2010.08.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
19 Pistarà V, Rescifina A, Punzo F, Greco G, Barbera V, Corsaro A. Design, Synthesis, Molecular Docking and Crystal Structure Prediction of New Azasugar Analogues of α-Glucosidase Inhibitors. Eur J Org Chem 2011;2011:7278-87. [DOI: 10.1002/ejoc.201100832] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
20 Shimokawa K, Yamada K, Ohno O, Oba Y, Uemura D. Design, synthesis, and biological evaluation of biotin-labeled (−)-ternatin, a potent fat-accumulation inhibitor against 3T3-L1 adipocytes. Bioorganic & Medicinal Chemistry Letters 2009;19:92-5. [DOI: 10.1016/j.bmcl.2008.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Sun J, Dong S, Wu Y, Zhao H, Li X, Gao W. Oleanolic acid and ursolic acid as potential inhibitors of human salivary α-amylase: insights from in vitro assays and in silico simulations. J Mol Model 2017;23. [DOI: 10.1007/s00894-017-3416-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Kordik CP, Luo C, Zanoni BC, Dax SL, Mcnally JJ, Lovenberg TW, Wilson SJ, Reitz AB. Aminopyrazoles with high affinity for the human neuropeptide Y5 receptor. Bioorganic & Medicinal Chemistry Letters 2001;11:2283-6. [DOI: 10.1016/s0960-894x(01)00448-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
23 Ulgar V, López Ó, Maya I, Fernández-bolaños JG, Bols M. Synthesis of furan 4′-thio-C-nucleosides, their methylsulfonium and sulfoxide derivatives. Evaluation as glycosidase inhibitors. Tetrahedron 2003;59:2801-9. [DOI: 10.1016/s0040-4020(03)00339-9] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
24 Gao Y, Cao Z, Zhang Q, Guo R, Ding F, You Q, Bi J, Zhang Y. Total Synthesis of the Proposed Structure of Penasulfate A: l -Arabinose as a Source of Chirality. J Nat Prod 2019;82:1908-16. [DOI: 10.1021/acs.jnatprod.9b00245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Xie W, Tanabe G, Akaki J, Morikawa T, Ninomiya K, Minematsu T, Yoshikawa M, Wu X, Muraoka O. Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Bioorg Med Chem 2011;19:2015-22. [PMID: 21345683 DOI: 10.1016/j.bmc.2011.01.052] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
26 Hu B, Malamas M, Ellingboe J, Largis E, Han S, Mulvey R, Tillett J. New oxadiazolidinedione derivatives as potent and selective human beta3 agonists. Bioorg Med Chem Lett 2001;11:981-4. [PMID: 11327605 DOI: 10.1016/s0960-894x(01)00147-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
27 de Oliveira MH, Ferreira PC, Carlos G, Salazar FR, Bergold AM, Pechansky F, Limberger RP, Fröehlich PE. Validation and application of a liquid chromatography-electrospray ionization mass spectrometric method for determination of mazindol in human plasma and urine. J Pharmacol Toxicol Methods 2016;79:1-6. [PMID: 26718151 DOI: 10.1016/j.vascn.2015.12.003] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Dehli JR, Gotor V. Dynamic kinetic resolution of 2-oxocycloalkanecarbonitriles: chemoenzymatic syntheses of optically active yclic beta- and gamma-amino alcohols. J Org Chem 2002;67:6816-9. [PMID: 12227816 DOI: 10.1021/jo0257288] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
29 Lee Y, Kim S, Kim JY, Arooj M, Kim S, Hwang S, Kim BW, Park KH, Lee KW. Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors. PLoS One 2014;9:e85827. [PMID: 24465730 DOI: 10.1371/journal.pone.0085827] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
30 Washburn W, Sher P, Poss K, Girotra R, Mccann P, Gavai A, Mikkilineni A, Mathur A, Cheng P, Dejneka T, Sun C, Wang T, Harper T, Russell A, Slusarchyk D, Skwish S, Allen G, Hillyer D, Frohlich B, Abboa-offei B, Cap M, Waldron T, George R, Tesfamariam B, Ciosek C, Ryono D, Young D, Dickinson K, Seymour A, Arbeeny C, Gregg R. Beta 3 agonists. Part 1: evolution from inception to BMS-194449. Bioorganic & Medicinal Chemistry Letters 2001;11:3035-9. [DOI: 10.1016/s0960-894x(01)00628-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
31 Le Merrer Y, Sanière M, Mccort I, Dupuy C, Depezay J. Carbohydrate mimics: analogues of aza-di-(or tri-)saccharides. Tetrahedron Letters 2001;42:2661-3. [DOI: 10.1016/s0040-4039(01)00242-8] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
32 Campos F, Bosch M, Guerrero A. An efficient enantioselective synthesis of ( R,R )-formoterol, a potent bronchodilator, using lipases. Tetrahedron: Asymmetry 2000;11:2705-17. [DOI: 10.1016/s0957-4166(00)00238-x] [Cited by in Crossref: 34] [Article Influence: 1.5] [Reference Citation Analysis]
33 Winter HD, Breslin H, Miskowski T, Kavash R, Somers M. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II. Journal of Molecular Graphics and Modelling 2005;23:409-18. [DOI: 10.1016/j.jmgm.2004.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Xie W, Tanabe G, Tsutsui N, Wu X, Muraoka O. Total synthesis of neokotalanol, a potent α-glucosidase inhibitor isolated from Salacia reticulata. Chinese Journal of Natural Medicines 2013;11:676-83. [DOI: 10.1016/s1875-5364(13)60079-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
35 Le Merrer Y, Gauzy L, Gravier-pelletier C, Depezay J. Synthesis of C 2 -symmetric guanidino-sugars as potent inhibitors of glycosidases. Bioorganic & Medicinal Chemistry 2000;8:307-20. [DOI: 10.1016/s0968-0896(99)00294-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
36 Borges de Melo E, da Silveira Gomes A, Carvalho I. α- and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 2006;62:10277-302. [DOI: 10.1016/j.tet.2006.08.055] [Cited by in Crossref: 404] [Cited by in F6Publishing: 272] [Article Influence: 25.3] [Reference Citation Analysis]
37 Danish M, Bibi A, Gilani K, Raza MA, Ashfaq M, Arshad MN, Asiri AM, Ayub K. Antiradical, antimicrobial and enzyme inhibition evaluation of sulfonamide derived esters; synthesis, X-Ray analysis and DFT studies. Journal of Molecular Structure 2019;1175:379-88. [DOI: 10.1016/j.molstruc.2018.07.116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
38 Stearns RA, Miller RR, Tang W, Kwei GY, Tang FS, Mathvink RJ, Naylor EM, Chitty D, Colandrea VJ, Weber AE, Colletti AE, Strauss JR, Keohane CA, Feeney WP, Iliff SA, Chiu SL. The Pharmacokinetics of a Thiazole Benzenesulfonamide β 3 -Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral Bioavailability. Drug Metab Dispos 2002;30:771-7. [DOI: 10.1124/dmd.30.7.771] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
39 Li G, Cai C, He J, Rao L, Ma L, Liu Y, Wang B. Synthesis of 3-acyloxyxanthone derivatives as α-glucosidase inhibitors: A further insight into the 3-substituents’ effect. Bioorganic & Medicinal Chemistry 2016;24:1431-8. [DOI: 10.1016/j.bmc.2016.01.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
40 Hickman AB, Namboodiri MA, Klein DC, Dyda F. The structural basis of ordered substrate binding by serotonin N-acetyltransferase: enzyme complex at 1.8 A resolution with a bisubstrate analog. Cell 1999;97:361-9. [PMID: 10319816 DOI: 10.1016/s0092-8674(00)80745-x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
41 Kandra L, Gyémánt G, Zajácz Á, Batta G. Inhibitory effects of tannin on human salivary α-amylase. Biochemical and Biophysical Research Communications 2004;319:1265-71. [DOI: 10.1016/j.bbrc.2004.05.122] [Cited by in Crossref: 88] [Cited by in F6Publishing: 73] [Article Influence: 4.9] [Reference Citation Analysis]
42 Blum CA, Zheng X, De Lombaert S. Design, synthesis, and biological evaluation of substituted 2-cyclohexyl-4-phenyl-1H-imidazoles: potent and selective neuropeptide Y Y5-receptor antagonists. J Med Chem 2004;47:2318-25. [PMID: 15084130 DOI: 10.1021/jm030490g] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
43 Tang W, Stearns RA, Miller RR, Ngui JS, Mathvink RJ, Weber AE, Kwei GY, Strauss JR, Keohane CA, Doss GA, Chiu SL, Baillie TA. Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β 3 -Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate. Drug Metab Dispos 2002;30:778-87. [DOI: 10.1124/dmd.30.7.778] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
44 Fern??ndez-l??pez J, Remesar X, Foz M, Alemany M. Pharmacological Approaches for the Treatment of Obesity: . Drugs 2002;62:915-44. [DOI: 10.2165/00003495-200262060-00005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
45 Paliwal S, Yadav D, Yadav R, Kaushik V, Paliwal S. Common binding requirements of PPAR-α/δ/γ pan agonists: quantitative structure–activity relationship analysis of indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail group. Med Chem Res 2012;21:891-907. [DOI: 10.1007/s00044-011-9599-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Ling AL. Neuropeptide Y receptor antagonists. Expert Opinion on Therapeutic Patents 2005;9:375-84. [DOI: 10.1517/13543776.9.4.375] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
47 Breslin HJ, Miskowski TA, Kukla MJ, Leister WH, De Winter HL, Gauthier DA, Somers MVF, Peeters DCG, Roevens PWM. Design, Synthesis, and Tripeptidyl Peptidase II Inhibitory Activity of a Novel Series of ( S )-2,3-Dihydro-2-(4-alkyl-1 H -imidazol-2-yl)-1 H -indoles. J Med Chem 2002;45:5303-10. [DOI: 10.1021/jm0202831] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
48 Chochkova MG, Petrova PP, Stoykova BM, Ivanova GI, Štícha M, Dibó G, Milkova TS. Structure-Activity Relationships of N -Cinnamoyl and Hydroxycinnamoyl Amides on α -Glucosidase Inhibition. Journal of Chemistry 2017;2017:1-5. [DOI: 10.1155/2017/6080129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Griffith RK. Adrenergics and Adrenergic‐Blocking Agents. Burger's Medicinal Chemistry and Drug Discovery. Wiley; 2003. pp. 1-37. [DOI: 10.1002/0471266949.bmc093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
50 Wikberg JE. Melanocortin receptors: new opportunities in drug discovery. Expert Opinion on Therapeutic Patents 2005;11:61-76. [DOI: 10.1517/13543776.11.1.61] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
51 Bouneva I, Kirby DF. Management of nonalcoholic fatty liver disease: weight control. Clinics in Liver Disease 2004;8:693-713. [DOI: 10.1016/j.cld.2004.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
52 Narender T, Shweta S, Tiwari P, Papi Reddy K, Khaliq T, Prathipati P, Puri A, Srivastava AK, Chander R, Agarwal SC, Raj K. Antihyperglycemic and antidyslipidemic agent from Aegle marmelos. Bioorg Med Chem Lett 2007;17:1808-11. [PMID: 17197179 DOI: 10.1016/j.bmcl.2006.12.037] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 4.4] [Reference Citation Analysis]
53 Ferry G, Ubeaud C, Mozo J, Péan C, Hennig P, Rodriguez M, Scoul C, Bonnaud A, Nosjean O, Galizzi JP, Delagrange P, Renard P, Volland JP, Yous S, Lesieur D, Boutin JA. New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors. Eur J Biochem 2004;271:418-28. [PMID: 14717709 DOI: 10.1046/j.1432-1033.2003.03942.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
54 Loizzo MR, Di Lecce G, Boselli E, Bonesi M, Menichini F, Menichini F, Frega NG. In vitro antioxidant and hypoglycemic activities of Ethiopian spice blend Berbere. International Journal of Food Sciences and Nutrition 2011;62:740-9. [DOI: 10.3109/09637486.2011.573470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Kandra L, Remenyik J, Batta G, Somsák L, Gyémánt G, Park KH. Enzymatic synthesis of a new inhibitor of α-amylases: acarviosinyl-isomaltosyl-spiro-thiohydantoin. Carbohydrate Research 2005;340:1311-7. [DOI: 10.1016/j.carres.2005.03.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
56 Luyen BT, Tai BH, Thao NP, Yang SY, Cuong NM, Kwon YI, Jang HD, Kim YH. A new phenylpropanoid and an alkylglycoside from Piper retrofractum leaves with their antioxidant and α-glucosidase inhibitory activity. Bioorg Med Chem Lett 2014;24:4120-4. [PMID: 25127165 DOI: 10.1016/j.bmcl.2014.07.057] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
57 Hu B, Jennings LL. Orally Bioavailable β3-Adrenergic Receptor Agonists as Potential Therapeutic Agents for Obesityand Type-II Diabetes. Elsevier; 2003. pp. 167-94. [DOI: 10.1016/s0079-6468(02)41005-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
58 Chen J, Pu Y, Pei H, He L, Fu S, Chen L. Synthesis and biological evaluation of tert-butyl-5-methylpyrimidin-piperazine derivatives as anti-obesity agents. Arch Pharm (Weinheim) 2014;347:908-22. [PMID: 25220533 DOI: 10.1002/ardp.201400227] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
59 Kim S, Kim JH, Seok SH, Park ES. Anti-obesity effect with reduced adverse effect of the co-administration of mini-tablets containing orlistat and mini-tablets containing xanthan gum: In vitro and in vivo evaluation. Int J Pharm 2020;591:119998. [PMID: 33115696 DOI: 10.1016/j.ijpharm.2020.119998] [Reference Citation Analysis]
60 Guery S, Rival Y, Wermuth CG. EFFICIENT SYNTHESIS OF A SELECTIVE Y5 RECEPTOR ANTAGONIST. Synthetic Communications 2002;32:1715-9. [DOI: 10.1081/scc-120004266] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
61 Breslin HJ, Miskowski TA, Kukla MJ, De Winter HL, Somers MV, Roevens PW, Kavash RW. Tripeptidyl-peptidase II (TPP II) inhibitory activity of ( S )-2,3-dihydro-2-(1 H -imidazol-2-yl)-1 H -indoles, a systematic SAR evaluation. Part 2. Bioorganic & Medicinal Chemistry Letters 2003;13:4467-71. [DOI: 10.1016/j.bmcl.2003.09.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
62 Shearer BG, Chao EY, Uehling DE, Deaton DN, Cowan C, Sherman BW, Milliken T, Faison W, Brown K, Adkison KK, Lee F. Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids. Bioorganic & Medicinal Chemistry Letters 2007;17:4670-7. [DOI: 10.1016/j.bmcl.2007.05.069] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
63 Conforti F, Statti GA, Tundis R, Loizzo MR, Menichini F. In vitro activities of Citrus medica L. cv. Diamante (Diamante citron) relevant to treatment of diabetes and Alzheimer's disease. Phytother Res 2007;21:427-33. [PMID: 17236166 DOI: 10.1002/ptr.2077] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
64 Raut N, Dhore P, Saoji S, Kokare D. Selected Bioactive Natural Products for Diabetes Mellitus. Elsevier; 2016. pp. 287-322. [DOI: 10.1016/b978-0-444-63602-7.00009-6] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
65 Washburn W, Sun C, Bisacchi G, Wu G, Cheng P, Sher P, Ryono D, Gavai A, Poss K, Girotra R, Mccann P, Mikkilineni A, Dejneka T, Wang T, Merchant Z, Morella M, Arbeeny C, Harper T, Slusarchyk D, Skwish S, Russell A, Allen G, Tesfamariam B, Frohlich B, Abboa-offei B, Cap M, Waldron T, George R, Young D, Dickinson K, Seymour A. BMS-201620: a selective beta 3 agonist. Bioorganic & Medicinal Chemistry Letters 2004;14:3525-9. [DOI: 10.1016/j.bmcl.2004.04.074] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
66 Kushner RF. Anti-obesity drugs. Expert Opin Pharmacother 2008;9:1339-50. [PMID: 18473708 DOI: 10.1517/14656566.9.8.1339] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
67 Sum FW, Gilbert A, Venkatesan AM, Lim K, Wong V, O'Dell M, Francisco G, Chen Z, Grosu G, Baker J, Ellingboe J, Malamas M, Gunawan I, Primeau J, Largis E, Steiner K. Prodrugs of CL316243: a selective beta3-adrenergic receptor agonist for treating obesity and diabetes. Bioorg Med Chem Lett 1999;9:1921-6. [PMID: 10450954 DOI: 10.1016/s0960-894x(99)00316-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Vongvilai P, Larsson R, Ramström O. Direct Asymmetric Dynamic Kinetic Resolution by Combined Lipase Catalysis and Nitroaldol (Henry) Reaction. Adv Synth Catal 2008;350:448-52. [DOI: 10.1002/adsc.200700432] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
69 Dehli JR, Gotor V. Enantio- and chemoselective bioreduction of β-keto nitriles by the fungus Curvularia lunata. Tetrahedron: Asymmetry 2000;11:3693-700. [DOI: 10.1016/s0957-4166(00)00348-7] [Cited by in Crossref: 39] [Article Influence: 1.8] [Reference Citation Analysis]
70 Wieland HA, Hamilton BS, Krist B, Doods HN. The role of NPY in metabolic homeostasis: implications for obesity therapy. Expert Opinion on Investigational Drugs 2005;9:1327-46. [DOI: 10.1517/13543784.9.6.1327] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
71 Palamara KL, Mogul HR, Peterson SJ, Frishman WH. Obesity: New Perspectives and Pharmacotherapies. Cardiology in Review 2006;14:238-58. [DOI: 10.1097/01.crd.0000233903.57946.fd] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
72 Gurwitz D. The therapeutic potential of nicotine and nicotinic agonists for weight control. Expert Opinion on Investigational Drugs 2005;8:747-60. [DOI: 10.1517/13543784.8.6.747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
73 Liu J, He S, Jian T, Dobbelaar PH, Sebhat IK, Lin LS, Goodman A, Guo C, Guzzo PR, Hadden M, Henderson AJ, Pattamana K, Ruenz M, Sargent BJ, Swenson B, Yet L, Tamvakopoulos C, Peng Q, Pan J, Kan Y, Palyha O, Kelly TM, Guan X, Howard AD, Marsh DJ, Metzger JM, Reitman ML, Wyvratt MJ, Nargund RP. Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters 2010;20:2074-7. [DOI: 10.1016/j.bmcl.2010.02.076] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
74 Hu B, Ellingboe J, Han S, Largis E, Lim K, Malamas M, Mulvey R, Niu C, Oliphant A, Pelletier J, Singanallore T, Sum FW, Tillett J, Wong V. Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists. Bioorg Med Chem 2001;9:2045-59. [PMID: 11504641 DOI: 10.1016/s0968-0896(01)00114-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
75 Kushner RF. Pharmacologic management of obesity: Pharmacologic Management of Obesity. Pediatr Blood Cancer 2012;58:140-3. [DOI: 10.1002/pbc.23366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Sum F, Wong V, Han S, Largis E, Mulvey R, Tillett J. Cyclic amine sulfonamides as linkers in the design and synthesis of novel human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters 2003;13:2191-4. [DOI: 10.1016/s0960-894x(03)00387-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
77 See R. The Role of Neurotransmitter Receptors in the Adverse Effects of Antipsychotic Drugs. In: Lidow M, editor. Neurotransmitter Receptors in Actions of Antipsychotic Medications. CRC Press; 2000. pp. 221-42. [DOI: 10.1201/9781420041774.ch14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
78 Sun Y, Chen JDz. Rimonabant, gastrointestinal motility and obesity. Curr Neuropharmacol 2012;10:212-8. [PMID: 23449551 DOI: 10.2174/157015912803217297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
79 Cooke D, Bloom S. The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 2006;5:919-31. [PMID: 17080028 DOI: 10.1038/nrd2136] [Cited by in Crossref: 147] [Cited by in F6Publishing: 121] [Article Influence: 9.2] [Reference Citation Analysis]
80 Mathvink RJ, Tolman JS, Chitty D, Candelore MR, Cascieri MA, Colwell LF, Deng L, Feeney WP, Forrest MJ, Hom GJ, Macintyre DE, Miller RR, Stearns RA, Tota L, Wyvratt MJ, Fisher MH, Weber AE. Discovery of a Potent, Orally Bioavailable β 3 Adrenergic Receptor Agonist, ( R )- N -[4-[2-[[2-Hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide. J Med Chem 2000;43:3832-6. [DOI: 10.1021/jm000286i] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
81 Pàmies O, Bäckvall J. Chemoenzymatic Dynamic Kinetic Resolution of β-Halo Alcohols. An Efficient Route to Chiral Epoxides. J Org Chem 2002;67:9006-10. [DOI: 10.1021/jo026157m] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
82 Zhang J, Zheng Q, Li Z, Zhang H. Theoretical evaluation and improvement on the potency of the rhodanine-based inhibitors for human serotonin N -acetyltransferase. Molecular Simulation 2014;40:1201-8. [DOI: 10.1080/08927022.2013.854894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Loizzo MR, Tundis R, Menichini F, Pugliese A, Bonesi M, Solimene U, Menichini F. Chelating, antioxidant and hypoglycaemic potential of Muscari comosum (L.) Mill. bulb extracts. Int J Food Sci Nutr 2010;61:780-91. [PMID: 20465433 DOI: 10.3109/09637486.2010.482521] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
84 Harada H, Fujii A, Odai O, Kato S. Process Development of a Scaleable Route to (2 R )-[3-(2-Aminopropyl)-1 H -indol-7-yloxy]- N,N -diethylacetamide:  A Key Intermediate for AJ-9677, a Potent and Selective Human and Rat β 3 -Adrenergic Receptor Agonist. Org Process Res Dev 2004;8:238-45. [DOI: 10.1021/op0341869] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
85 Alig L, Alsenz J, Andjelkovic M, Bendels S, Bénardeau A, Bleicher K, Bourson A, David-Pierson P, Guba W, Hildbrand S, Kube D, Lübbers T, Mayweg AV, Narquizian R, Neidhart W, Nettekoven M, Plancher JM, Rocha C, Rogers-Evans M, Röver S, Schneider G, Taylor S, Waldmeier P. Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity. J Med Chem 2008;51:2115-27. [PMID: 18335976 DOI: 10.1021/jm701487t] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
86 Mathvink RJ, Tolman J, Chitty D, Candelore MR, Cascieri MA, Colwell LF, Deng L, Feeney WP, Forrest MJ, Hom GJ, Macintyre D, Tota L, Wyvratt MJ, Fisher MH, Weber AE. Potent, selective 3-pyridylethanolamine β3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore. Bioorganic & Medicinal Chemistry Letters 2000;10:1971-3. [DOI: 10.1016/s0960-894x(00)00390-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Xie W, Tanabe G, Matsuoka K, Amer MF, Minematsu T, Wu X, Yoshikawa M, Muraoka O. Role of the side chain stereochemistry in the α-glucosidase inhibitory activity of kotalanol, a potent natural α-glucosidase inhibitor. Bioorganic & Medicinal Chemistry 2011;19:2252-62. [DOI: 10.1016/j.bmc.2011.02.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
88 Finn J, Pelham D, Walker MW, Gluchowski C. High-throughput synthesis optimization of sulfonamide NPY Y5 antagonists. Bioorganic & Medicinal Chemistry Letters 2002;12:1771-4. [DOI: 10.1016/s0960-894x(02)00288-3] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
89 Yang HY, Tae J, Seo YW, Kim YJ, Im HY, Choi GD, Cho H, Park WK, Kwon OS, Cho YS, Ko M, Jang H, Lee J, Choi K, Kim CH, Lee J, Pae AN. Novel pyrimidoazepine analogs as serotonin 5-HT(2A) and 5-HT(2C) receptor ligands for the treatment of obesity. Eur J Med Chem 2013;63:558-69. [PMID: 23537943 DOI: 10.1016/j.ejmech.2013.02.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
90 Sun J, Dong S, Wu Y, Zhao H, Li X, Gao W. Inhibitor discovery from pomegranate rind for targeting human salivary α-amylase. Med Chem Res 2018;27:1559-77. [DOI: 10.1007/s00044-018-2164-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
91 Zhu D, Hyatt BA, Hua L. Enzymatic hydrogen transfer reduction of α-chloro aromatic ketones catalyzed by a hyperthermophilic alcohol dehydrogenase. Journal of Molecular Catalysis B: Enzymatic 2009;56:272-6. [DOI: 10.1016/j.molcatb.2008.05.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
92 Pierson PD, Fettes A, Freichel C, Gatti-mcarthur S, Hertel C, Huwyler J, Mohr P, Nakagawa T, Nettekoven M, Plancher J, Raab S, Richter H, Roche O, Rodríguez Sarmiento RM, Schmitt M, Schuler F, Takahashi T, Taylor S, Ullmer C, Wiegand R. 5-Hydroxyindole-2-carboxylic Acid Amides: Novel Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity. J Med Chem 2009;52:3855-68. [DOI: 10.1021/jm900409x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
93 Carpino PA. Patent focus on new anti-obesity agents: September 1999 - February 2000. Expert Opinion on Therapeutic Patents 2005;10:819-31. [DOI: 10.1517/13543776.10.6.819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
94 Ikemoto N, Liu J, Brands KM, Mcnamara JM, Reider PJ. Practical routes to the triarylsulfonyl chloride intermediate of a β3 adrenergic receptor agonist. Tetrahedron 2003;59:1317-25. [DOI: 10.1016/s0040-4020(03)00018-8] [Cited by in Crossref: 21] [Article Influence: 1.1] [Reference Citation Analysis]
95 Sakulsombat M, Zhang Y, Ramström O. Dynamic Systemic Resolution. In: Barboiu M, editor. Constitutional Dynamic Chemistry. Berlin: Springer Berlin Heidelberg; 2012. pp. 55-86. [DOI: 10.1007/128_2011_203] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
96 Malki Y, Martinez J, Masurier N. 1,3-Diazepine: A privileged scaffold in medicinal chemistry. Med Res Rev 2021;41:2247-315. [PMID: 33645848 DOI: 10.1002/med.21795] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Cabrele C, Langer M, Bader R, Wieland HA, Doods HN, Zerbe O, Beck-Sickinger AG. The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem 2000;275:36043-8. [PMID: 10944518 DOI: 10.1074/jbc.M000626200] [Cited by in Crossref: 140] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
98 Hu B, Ellingboe J, Gunawan I, Han S, Largis E, Li Z, Malamas M, Mulvey R, Oliphant A, Sum F, Tillett J, Wong V. 2,4-thiazolidinediones as potent and selective human β3 agonists. Bioorganic & Medicinal Chemistry Letters 2001;11:757-60. [DOI: 10.1016/s0960-894x(01)00063-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
99 Senthil Kumar P, Bharatam PV. Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists. Med Chem Res 2010;19:1121-40. [PMID: 21170122 DOI: 10.1007/s00044-009-9257-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Ibrar A, Zaib S, Khan I, Shafique Z, Saeed A, Iqbal J. New prospects for the development of selective inhibitors of α -glucosidase based on coumarin-iminothiazolidinone hybrids: Synthesis, in-vitro biological screening and molecular docking analysis. Journal of the Taiwan Institute of Chemical Engineers 2017;81:119-33. [DOI: 10.1016/j.jtice.2017.09.041] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
101 Pan K, Scott MK, Lee DH, Fitzpatrick LJ, Crooke JJ, Rivero RA, Rosenthal DI, Vaidya AH, Zhao B, Reitz AB. 2,3-Diaryl-5-anilino[1,2,4]thiadiazoles as melanocortin MC4 receptor agonists and their effects on feeding behavior in rats. Bioorganic & Medicinal Chemistry 2003;11:185-92. [DOI: 10.1016/s0968-0896(02)00428-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
102 Pelletier JC, Khan A, Tang Z. A Tandem Three-Phase Reaction for Preparing Secondary Amines with Minimal Side Products. Org Lett 2002;4:4611-3. [DOI: 10.1021/ol0269401] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
103 Richman A, Heinrichs SC. Seizure prophylaxis in an animal model of epilepsy by dietary fluoxetine supplementation. Epilepsy Res 2007;74:19-27. [PMID: 17215106 DOI: 10.1016/j.eplepsyres.2006.11.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
104 Kim SS, Lee HW, Lee KT. Validated method for determination of mazindol in human plasma by liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:1011-6. [PMID: 19272843 DOI: 10.1016/j.jchromb.2009.02.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
105 Meinke PT. Perspectives in animal health: old targets and new opportunities. J Med Chem 2001;44:641-59. [PMID: 11262075 DOI: 10.1021/jm990564h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]